MISSISSAUGA, ON , Nov. 22, 2011 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported that, in view of the unusual market activity in the common stock of the Company, the NYSE Amex has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market activity or market rumours, YM confirmed that it is not aware of any material corporate developments, including without limitation, any financing activities, which could account for the unusual trading activity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.